Lingam Meka, Ashok Thadisetty, Venkateswarlu Vobalaboina, Madhusudan Rao Yamsani
Centre for Biopharmaceutics and Pharmacokinetics, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, 506009 Andhra Pradesh, India.
AAPS PharmSciTech. 2008;9(4):1253-61. doi: 10.1208/s12249-008-9173-2. Epub 2008 Dec 31.
A biphasic gastroretentive floating drug delivery system with multiple-unit mini-tablets based on gas formation technique was developed to maintain constant plasma level of a drug concentration within the therapeutic window. The system consists of loading dose as uncoated core units, and prolonged-release core units are prepared by direct compression process; the latter were coated with three successive layers, one of which is seal coat, an effervescent (sodium bicarbonate) layer, and an outer polymeric layer of polymethacrylates. The formulations were evaluated for quality control tests, and all the parameters evaluated were within the acceptable limits. The system using Eudragit RL30D and combination of them as polymeric layer could float within acceptable time. The drug release was linear with the square root of time. The rapid floating and the controlled release properties were achieved in this present study. When compared with the theoretical release profile, the similarity factor of formulation with coating of RS:RL (1:3)-7.5%, was observed to be 74, which is well fitted into zero-order kinetics confirming that the release from formulation is close to desired release profile. The stability samples showed no significant change in dissolution profiles (p > 0.05). In vivo gastric residence time was examined by radiograms, and it was observed that the units remained in the stomach for about 5 h.
基于气体形成技术开发了一种具有多单元微型片剂的双相胃滞留漂浮药物递送系统,以在治疗窗内维持药物浓度的恒定血浆水平。该系统由作为未包衣核心单元的负荷剂量组成,延长释放核心单元通过直接压片工艺制备;后者涂有三层连续的层,其中一层是密封层、一层泡腾(碳酸氢钠)层和一层聚甲基丙烯酸酯外聚合物层。对制剂进行了质量控制测试,所有评估参数均在可接受范围内。使用Eudragit RL30D及其组合作为聚合物层的系统可在可接受的时间内漂浮。药物释放与时间的平方根呈线性关系。在本研究中实现了快速漂浮和控释特性。与理论释放曲线相比,观察到RS:RL(1:3)-7.5%包衣制剂的相似因子为74,很好地符合零级动力学,证实制剂的释放接近所需释放曲线。稳定性样品的溶出曲线无显著变化(p>0.05)。通过X光片检查体内胃滞留时间,观察到这些单元在胃中停留约5小时。